Circulating Antibodies Recognizing Oxidatively Modified Low-Density Lipoprotein in Children

article

Circulating Antibodies Recognizing Oxidatively Modified Low-Density Lipoprotein in Children is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1064214084
P356DOI10.1203/00006450-199901000-00016
P698PubMed publication ID9890615

P50authorLorenzo IughettiQ43707528
P2093author name stringBernasconi S
Maggi E
Volta C
Bellomo G
Palladini G
Perugini C
P2860cites workProbucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbitsQ28359752
Smooth muscle cells and the pathogenesis of the lesions of atherosclerosisQ33613211
Low density lipoprotein undergoes oxidative modification in vivoQ33838672
Minimally modified low density lipoprotein stimulates monocyte endothelial interactionsQ34248823
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosQ34360883
The role of lipid peroxidation and antioxidants in oxidative modification of LDL.Q35379559
Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophagesQ36364861
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasmaQ37358413
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoproteinQ37358421
Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implicationsQ39684650
The oxidation hypothesis of atherosclerosisQ40625668
Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patientsQ42123775
The pediatric aspects of atherosclerosisQ45080940
Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDLQ56637610
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectlipoproteinQ28350
antibodyQ79460
P304page(s)94-99
P577publication date1999-01-01
P1433published inPediatric ResearchQ7159215
P1476titleCirculating antibodies recognizing oxidatively modified low-density lipoprotein in children
P478volume45

Reverse relations

cites work (P2860)
Q58493466Approaches to dyslipidemia treatment in children and adolescents
Q44287982Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease
Q31880890Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects.
Q38863066Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus
Q36359710Intravenous immunoglobulin and atherosclerosis
Q34072528Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.
Q33551868Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins
Q36283424Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Q36965617Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.
Q35008989Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarction
Q43251127Vaccination, atherosclerosis and systemic lupus erythematosus

Search more.